share_log

Oppenheimer Upgrades Ventyx Biosciences to Outperform, Announces $12 Price Target

Oppenheimer Upgrades Ventyx Biosciences to Outperform, Announces $12 Price Target

奧本海默將Ventyx Biosciences上調至跑贏大盤,宣佈目標股價爲12美元
Benzinga ·  03/12 04:56

Oppenheimer analyst Jeff Jones upgrades Ventyx Biosciences (NASDAQ:VTYX) from Perform to Outperform and announces $12 price target.

奧本海默分析師傑夫·瓊斯將Ventyx Biosciences(納斯達克股票代碼:VTYX)從表現上調至跑贏大盤,並宣佈目標股價爲12美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論